Who founded Ankyra Therapeutics?

Ankyra Therapeutics was founded by Tillman Gerngross in 2019.

Who are Ankyra Therapeutics's investors?

Ankyra Therapeutics's investors include GV (Google Ventures), Mithril Capital Management, Polaris Partners.

How much funding has Ankyra Therapeutics raised?

Ankyra Therapeutics has disclosed $59.5M raised across 2 rounds.

Where is Ankyra Therapeutics headquartered?

Ankyra Therapeutics is headquartered in Austin, US.

Ankyra Therapeutics

Austin, US · Founded 2019 · Delaware corporation · 3 known investors

ankyratx.com ↗

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

Ankyra Therapeutics was founded in 2019 by Tillman Gerngross.

Tillman GerngrossFounder

Board

Terrance McGuireBoard director

Investors · 3

GV (Google Ventures)Mountain View · $250K – $50M

Mithril Capital ManagementreportedAustinvia Ajay Royan · board

Polaris PartnersreportedBoston · $500K – $5M

Reported raises · per SEC filings

Form D private placements

$59.5M disclosed across 2 rounds · 2020–2021

▶$45MraisedSep 2021 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ajay RoyanDirector
Terrance McGuireDirector
Tillman GerngrossExecutive Officer, Director
Philip FerneauDirector

Offering amount: $45M
Amount sold: $45M
First sale: Aug 2021
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$14.5MraisedMay 2020 · 4 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Terrance McGuireDirector
Tillman GerngrossExecutive Officer, Director

Offering amount: $14.5M
Amount sold: $14.5M
First sale: May 2020
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Bioworld31 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Ankyra Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ankyra Therapeutics do?: Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
Who founded Ankyra Therapeutics?: Ankyra Therapeutics was founded by Tillman Gerngross in 2019.
Who are Ankyra Therapeutics's investors?: Ankyra Therapeutics's investors include GV (Google Ventures), Mithril Capital Management, Polaris Partners.
How much funding has Ankyra Therapeutics raised?: Ankyra Therapeutics has disclosed $59.5M raised across 2 rounds.
Where is Ankyra Therapeutics headquartered?: Ankyra Therapeutics is headquartered in Austin, US.